GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,853,000 | +443.9% | 276,847 | +155.2% | 0.01% | +700.0% |
| Q2 2022 | $3,466,000 | -23.7% | 108,487 | -17.3% | 0.00% | -50.0% |
| Q1 2022 | $4,542,000 | +41.2% | 131,105 | +19.3% | 0.00% | +100.0% |
| Q4 2021 | $3,217,000 | -28.1% | 109,905 | -37.4% | 0.00% | 0.0% |
| Q3 2021 | $4,474,000 | +120.4% | 175,580 | +202.9% | 0.00% | 0.0% |
| Q2 2021 | $2,030,000 | -38.6% | 57,960 | -28.6% | 0.00% | 0.0% |
| Q1 2021 | $3,306,000 | +685.3% | 81,131 | +734.6% | 0.00% | – |
| Q4 2020 | $421,000 | +209.6% | 9,721 | +294.4% | 0.00% | – |
| Q3 2020 | $136,000 | -60.8% | 2,465 | -55.1% | 0.00% | – |
| Q2 2020 | $347,000 | -41.6% | 5,493 | -52.8% | 0.00% | – |
| Q1 2020 | $594,000 | -96.0% | 11,635 | -93.8% | 0.00% | -100.0% |
| Q4 2019 | $15,003,000 | +153.9% | 188,750 | +55.0% | 0.01% | +150.0% |
| Q3 2019 | $5,908,000 | +57.6% | 121,765 | +70.9% | 0.00% | +100.0% |
| Q2 2019 | $3,748,000 | +197.5% | 71,258 | +199.2% | 0.00% | 0.0% |
| Q1 2019 | $1,260,000 | -78.5% | 23,814 | -83.3% | 0.00% | -66.7% |
| Q4 2018 | $5,865,000 | +100.2% | 142,880 | +85.3% | 0.00% | +200.0% |
| Q3 2018 | $2,930,000 | -7.7% | 77,097 | +9.8% | 0.00% | 0.0% |
| Q2 2018 | $3,173,000 | -51.8% | 70,208 | -48.5% | 0.00% | -66.7% |
| Q1 2018 | $6,588,000 | +344.5% | 136,394 | +262.3% | 0.00% | +200.0% |
| Q4 2017 | $1,482,000 | -33.9% | 37,643 | -47.8% | 0.00% | 0.0% |
| Q3 2017 | $2,241,000 | +16.5% | 72,170 | +2.6% | 0.00% | 0.0% |
| Q2 2017 | $1,924,000 | +40.2% | 70,343 | +89.0% | 0.00% | 0.0% |
| Q1 2017 | $1,372,000 | -35.8% | 37,223 | -71.1% | 0.00% | 0.0% |
| Q2 2016 | $2,137,000 | +1.9% | 128,813 | -2.6% | 0.00% | 0.0% |
| Q1 2016 | $2,097,000 | -69.9% | 132,209 | -38.6% | 0.00% | -80.0% |
| Q4 2015 | $6,965,000 | – | 215,431 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |